Sarepta Therapeutics Statistics
NASDAQ: SRPTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.33-0.84 (-5.93%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Sarepta Therapeutics by the numbers
Sarepta Therapeutics has a market capitalization of $1.43 billion based on 107.24M shares outstanding. Its trailing P/E ratio is 666.5, above the 3-company peer median of 7.2, and its forward P/E is 8.9. The stock trades 25.5% below its 50-day average and 27.5% below its 200-day average.
Average daily trading volume is 2.70M shares, or about $36.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SRPT valuation vs. peer median
| Metric | SRPT | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.43B | $1.40B | +2% |
| Avg. volume | 2.70M | 821.59K | +229% |
Peer median across 8 companies: KLRA, ADRX, DMRA, NRIX, TYRA, ANAB, RAPP, QURE.
Valuation
- Market cap
- $1.43B
- Forward P/E
- 8.87
- Price / sales (latest FY)
- 0.65
- EPS (TTM)
- $0.02
- Shares outstanding
- 107.24M
Price and trading
- Previous close
- 14.17
- Open
- 13.93
- Day range
- 13.25 – 14.47
- 52-week range
- 13.25 – 24.68
- 52-week change
- -24.65%
- Beta
- —
- Volume
- 2.24M
- Average volume
- 2.70M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.43B
- Pe
- 666.50
- Forward Pe
- 8.87
- Eps
- 0.02
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 24.68
- Week52 Low
- 13.25
- Avg Volume
- 2.70M
- Shares Outstanding
- 107.24M
- Ma50
- 17.90
- Ma200
- 18.38
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -45.99%
- Pct From52w Low
- 0.60%